Physician profile
Lance Meyerson
NPI 1437143104
$4,614.98
in general payments reported to CMS, 2019-2025
14 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,146 · 2020: $360 · 2021: $388 · 2022: $379 · 2023: $180 · 2024: $57.47 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,944.37 | 2019-2024 | Xpress Ent Dilation System, Xpress Loprofile |
| Optinose US, INC. | $206.51 | 2022-2025 | |
| Intersect Ent, INC. | $123.61 | 2019-2021 | |
| Aerin Medical INC. | $70.40 | 2019-2025 | |
| Karl Storz Endoscopy-America | $66.03 | 2019-2025 | Image1 S Connect |
| Medtronic, INC. | $57.45 | 2025 | Propel |
| Acclarent, INC | $44.91 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $22.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.51 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.42 | 2023 | Uzedy |
| Arbor Pharmaceuticals, INC. | $15.08 | 2020 | |
| Hikma Pharmaceuticals USA | $14.08 | 2024 | Ryaltris |
| Integra Lifesciences Corporation | $12.87 | 2020 | |
| Ambu INC. | $4.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Meyerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.